Tranexamic Acid for Reducing Blood Loss During C-Sections

Prophylactic Tranexamic Acid To Reduce Blood Loss During Caesarean Delivery.

Recruiting N/A Interventional Study
Post Partum Hemorrhage
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 45
Sex
Female
Study type
Interventional
Purpose
Prevention
Participants needed
300 (estimated)
Sponsor
Aligarh Muslim University · Other
Who this trial is looking for

This trial is looking for women who are having a cesarean delivery. By joining, you will receive tranexamic acid to see if it helps reduce blood loss during the surgery.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am having a cesarean delivery.
  • I am willing to participate in the study.

You may not be able to join if

  • I am critically ill.
  • I do not want to give consent to participate.
  • I have a ruptured uterus.
  • I am undergoing a caesarean hysterectomy.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Postpartum hemorrhage continues to be the leading cause of maternal morbidity and mortality. Globally, it is responsible for 25% of all pregnancy-related deaths. PPH is unpredictable and may occur in the absence of risk factors. Tranexamic acid is an antifibrinolytic proven to reduce blood loss and transfusion requirements for various surgeries. This study aims to explore the effectiveness of tran…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. The women undergoing cesarean delivery (both elective and emergency) during the study period. 2. Willing to participate in the study after understanding the concept. Exclusion Criteria: 1. Critically ill patient. 2. Not willing to give consent to participate in the study 3.…
Contacts

MUAZZAM HASAN, MD

9808447427

MUAZZAMSH@GMAIL.COM

CONTACT